Protalix BioTherapeutics任命Gilad Mamlok为首席财务官

2025-07-21 19:00

Protalix BioTherapeutics (NYSE:PLX) Monday announced the appointment of Gilad Mamlok to serve as the company's new Senior Vice President and Chief Financial Officer, effective August 24, succeeding Eyal Rubin.
To ensure a seamless transition, Mamlok has joined the company and is working alongside Rubin.
After his tenure as Chief Financial Officer ends, Rubin will continue to be available to the Company as necessary until October 2025.
Most recently, he served as the CFO of TytoCare, a privately held company in the remote healthcare space.

More on Protalix BioTherapeutics